These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3698122)

  • 1. The degradation of 5-iododeoxyuridine and 5-bromodeoxyuridine by serum from different sources and its consequences for the use of the compounds for incorporation into DNA.
    Saffhill R; Hume WJ
    Chem Biol Interact; 1986 Mar; 57(3):347-55. PubMed ID: 3698122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical modulation of 5-bromo-2'-deoxyuridine and 5-iodo-2'-deoxyuridine incorporation into DNA in VX2 tumor-bearing rabbits.
    Stetson PL; Normolle DP; Knol JA; Johnson NJ; Yang ZM; Sakmar E; Prieskorn D; Terrio P; Knutsen CA; Ensminger WD
    J Natl Cancer Inst; 1991 Nov; 83(22):1659-67. PubMed ID: 1836238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification of thymidine phosphorylase from Escherichia coli and its photoinactivation in the presence of thymine, thymidine, and some halogenated analogs.
    Voytek P
    J Biol Chem; 1975 May; 250(10):3660-5. PubMed ID: 236298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro DNA synthesis by megaloblastic bone marrow: effect of folates and cobalamins on thymidine incorporation and de novo thymidylate synthesis.
    Das KC; Herbert V
    Am J Hematol; 1989 May; 31(1):11-20. PubMed ID: 2705438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous high-performance liquid chromatographic assay for 5-(2-bromo-E-ethenyl)-2'-deoxyuridine and its metabolite, 5-(2-bromo-E-ethenyl)uracil, in plasma.
    Robinson Y; Gerry N; Vose CW
    J Chromatogr; 1985 Feb; 338(1):219-24. PubMed ID: 4019647
    [No Abstract]   [Full Text] [Related]  

  • 6. High-performance liquid chromatographic method for the determination of bromodeoxyuridine and its major metabolite, bromouracil, in biological fluids.
    Stetson PL; Shukla UA; Amin PR; Ensminger WD
    J Chromatogr; 1985 May; 341(1):217-22. PubMed ID: 4019689
    [No Abstract]   [Full Text] [Related]  

  • 7. Low doses of bromo- and iododeoxyuridine produce near-saturation labeling of adult proliferative populations in the dentate gyrus.
    Burns KA; Kuan CY
    Eur J Neurosci; 2005 Feb; 21(3):803-7. PubMed ID: 15733099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved high-performance liquid chromatographic assay for the quantification of 5-bromo-2'-deoxyuridine and 5-bromouracil in plasma.
    Ganes DA; Wagner JG
    J Chromatogr; 1988 Nov; 432():233-42. PubMed ID: 3220891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporation of 5-iodo-2'-deoxyuridine and 5-bromo-2'-deoxyuridine into rodent DNA as determined by neutron activation analysis.
    Kitchin KT; Brown JL
    Anal Biochem; 1995 Aug; 229(2):180-7. PubMed ID: 7485970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo SCE analysis using bromodeoxyuridine, iododeoxyuridine, and chlorodeoxyuridine.
    DuFrain RJ; McFee AF; Linkous S; Jennings CJ; Lowe KW
    Mutat Res; 1984 Feb; 139(2):57-60. PubMed ID: 6694663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition by 6-aminothymine of the degradation of nucleosides (5-iododeoxyuridine, thymidine) and pyrimidine bases (5-iodouracil, uracil and 5-fluorouracil) in vivo.
    Matthes E; Bärwolff D; Langen P
    Acta Biol Med Ger; 1974; 32(5):483-502. PubMed ID: 4852467
    [No Abstract]   [Full Text] [Related]  

  • 12. Mutual kinetic interaction between 5-fluorouracil and bromodeoxyuridine or iododeoxyuridine in dogs.
    Smith DE; Brenner DE; Knutsen CA; Deremer SJ; Terrio PA; Johnson NJ; Stetson PL; Ensminger WD
    Drug Metab Dispos; 1993; 21(2):277-83. PubMed ID: 8097697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THE EFFECT OF NATURAL AND UNNNATURAL PYRIMIDINES AND PYRIMIDINE NUCLEOSIDES ON THE PHOSPHOROLYSIS OF 5-IODODEOXYURIDINE BY MOUSE LIVER EXTRACT.
    KRISS JP; BOND SB
    Biochem Pharmacol; 1964 Mar; 13():365-70. PubMed ID: 14157596
    [No Abstract]   [Full Text] [Related]  

  • 14. Incorporation of thymidine and iodeoxyuridine in mammalian cells in vitro.
    Myers DK; Feinendegan LE
    J Cell Physiol; 1975 Dec; 86 Suppl 2(3 Pt 2):621-33. PubMed ID: 127803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex formation of uracil, 2'-deoxyuridine and their 5-halogenated derivatives.
    Tan YL; Beck A
    Biochim Biophys Acta; 1973 Apr; 299(4):500-6. PubMed ID: 4267683
    [No Abstract]   [Full Text] [Related]  

  • 16. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.
    Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Shimizu K; Seno T
    Mol Pharmacol; 1987 Sep; 32(3):410-6. PubMed ID: 2823092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free radicals in irradiated single crystals of 5-halo-uracil derivatives: 5-bromouracil, 5-bromodeoxyuridine and 5-iododeoxyuridine.
    Hüttermann J; Müller A
    Int J Radiat Biol Relat Stud Phys Chem Med; 1969; 15(4):297-313. PubMed ID: 4308485
    [No Abstract]   [Full Text] [Related]  

  • 18. The study of human myeloid differentiation using bromodeoxyuridine (BrdU).
    Keoffler HP; Yen J; Carlson J
    J Cell Physiol; 1983 Jul; 116(1):111-7. PubMed ID: 6574132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replication labeling with halogenated thymidine analogs.
    Yokochi T; Gilbert DM
    Curr Protoc Cell Biol; 2007 Jun; Chapter 22():Unit 22.10. PubMed ID: 18228503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical mechanisms in the Killmann experiment: critique of the deoxyuridine suppression test.
    Pelliniemi TT; Beck WS
    J Clin Invest; 1980 Feb; 65(2):449-60. PubMed ID: 6444307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.